| Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective DV Ratnam, DD Ankola, V Bhardwaj, DK Sahana, MNV Kumar Journal of Controlled Release 113 (3), 189-207, 2006 | 1301 | 2006 |
| Can controversial nanotechnology promise drug delivery? VR Devadasu, V Bhardwaj, MNVR Kumar Chemical reviews 113 (3), 1686-1735, 2013 | 236 | 2013 |
| Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure® in treating hyperlipidemia AK Meena, DV Ratnam, G Chandraiah, DD Ankola, PR Rao, ... Lipids 43 (3), 231-241, 2008 | 52 | 2008 |
| Protective effects of nanoparticulate coenzyme Q10 and curcumin on inflammatory markers and lipid metabolism in streptozotocin-induced diabetic rats: a possible … VR Devadasu, RM Wadsworth, MNVR Kumar Drug delivery and translational research 1, 448-455, 2011 | 47 | 2011 |
| Pharmacokinetics of colon-specific pH and time-dependent flurbiprofen tablets SK Vemula, PR Veerareddy, VR Devadasu European Journal of Drug Metabolism and Pharmacokinetics 40, 301-311, 2015 | 44 | 2015 |
| The co-encapsulated antioxidant nanoparticles of ellagic acid and coenzyme Q10 ameliorates hyperlipidemia in high fat diet fed rats DV Ratnam, G Chandraiah, AK Meena, P Ramarao, MNV Ravi Kumar Journal of Nanoscience and Nanotechnology 9 (11), 6741-6746, 2009 | 43 | 2009 |
| Physicochemical, pharmaceutical, and biological considerations in GIT absorption of drugs VR Devadasu, PK Deb, R Maheshwari, P Sharma, RK Tekade Dosage Form Design Considerations, 149-178, 2018 | 33 | 2018 |
| Simultaneous analysis of ellagic acid and coenzyme Q< sub> 10</sub> by derivative spectroscopy and HPLC DV Ratnam, V Bhardwaj, MNV Kumar Talanta 70 (2), 387-391, 2006 | 33 | 2006 |
| Pharmacokinetics of ketorolac tromethamine compression-coated tablets for colon delivery SK Vemula, PR Veerareddy, VR Devadasu Drug Delivery and Translational Research 4, 310-319, 2014 | 23 | 2014 |
| A potential therapeutic strategy for diabetes and its complications in the form of co-encapsulated antioxidant nanoparticles (NanoCAPs) of ellagic acid and coenzyme Q10 … DV Ratnam, G Chandraiah, K Sonaje, B Viswanad, V Bhardwaj, ... Journal of Biomedical Nanotechnology 4 (1), 33-43, 2008 | 20 | 2008 |
| Comparison of the safety information on drug labels in three developed countries: The USA, UK and Canada TM Alshammari, VR Devadasu, RP Rathnam Saudi pharmaceutical journal 25 (8), 1103-1107, 2017 | 18 | 2017 |
| Tissue localization of nanoparticles is altered due to hypoxia resulting in poor efficacy of curcumin nanoparticles in pulmonary hypertension VR Devadasu, RM Wadsworth, MNVR Kumar European journal of pharmaceutics and biopharmaceutics 80 (3), 578-584, 2012 | 18 | 2012 |
| Current advances in the utilization of nanotechnology for the diagnosis and treatment of diabetes VR Devadasu, TM Alshammari, M Aljofan International Journal of Diabetes in Developing Countries 38 (1), 11-19, 2018 | 17 | 2018 |
| Acute toxicity testing of newly discovered potential antihepatitis B virus agents of plant origin GM Subaiea, M Aljofan, VR Devadasu, TM Alshammari Asian Journal of Pharmaceutical and Clinical Research 10 (11), 210-213, 2017 | 7 | 2017 |
| Evaluation of antioxidants encapsulated nanoparticles in animal models VR Devadasu | | 2011 |
| NANOMEDICINES: THE PROMISE OF POLYMERIC NANOPARTICLES IN PER ORAL DRUG DELIVERY JL ITALIA, DD ANKOLA, D VENKAT RATNAM, V BHARDWAJ, ... Bulletin technique Gattefossé 101, 25-30, 2008 | | 2008 |
Vivekanand BhardwajPfizer IncVerified email at pfizer.com
